KR20040078074A - 감각요법을 사용하는 폐경기 관련 증상의 완화방법 - Google Patents
감각요법을 사용하는 폐경기 관련 증상의 완화방법 Download PDFInfo
- Publication number
- KR20040078074A KR20040078074A KR1020040014394A KR20040014394A KR20040078074A KR 20040078074 A KR20040078074 A KR 20040078074A KR 1020040014394 A KR1020040014394 A KR 1020040014394A KR 20040014394 A KR20040014394 A KR 20040014394A KR 20040078074 A KR20040078074 A KR 20040078074A
- Authority
- KR
- South Korea
- Prior art keywords
- corticosteroids
- amount
- menopause
- transitional
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000001953 sensory effect Effects 0.000 title claims abstract description 59
- 230000009245 menopause Effects 0.000 title claims abstract description 38
- 208000024891 symptom Diseases 0.000 title claims abstract description 15
- 238000000034 method Methods 0.000 title claims description 49
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 84
- 239000003246 corticosteroid Substances 0.000 claims abstract description 75
- 229960001334 corticosteroids Drugs 0.000 claims abstract description 66
- 230000000638 stimulation Effects 0.000 claims abstract description 33
- 230000000694 effects Effects 0.000 claims abstract description 24
- 230000004179 hypothalamic–pituitary–adrenal axis Effects 0.000 claims abstract description 19
- 238000010348 incorporation Methods 0.000 claims abstract description 12
- 230000000007 visual effect Effects 0.000 claims abstract description 9
- 230000000977 initiatory effect Effects 0.000 claims abstract description 6
- 208000033830 Hot Flashes Diseases 0.000 claims description 45
- 206010060800 Hot flush Diseases 0.000 claims description 45
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 18
- 229960000890 hydrocortisone Drugs 0.000 claims description 15
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 14
- 230000002040 relaxant effect Effects 0.000 claims description 12
- 238000002657 hormone replacement therapy Methods 0.000 claims description 10
- 230000002618 waking effect Effects 0.000 claims description 10
- 208000019116 sleep disease Diseases 0.000 claims description 9
- 206010029410 night sweats Diseases 0.000 claims description 8
- 230000036565 night sweats Effects 0.000 claims description 8
- 229930003231 vitamin Natural products 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- 239000002304 perfume Substances 0.000 claims description 4
- YKFCISHFRZHKHY-NGQGLHOPSA-N (2s)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid;trihydrate Chemical compound O.O.O.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1.OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 YKFCISHFRZHKHY-NGQGLHOPSA-N 0.000 claims description 3
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 claims description 3
- 206010047791 Vulvovaginal dryness Diseases 0.000 claims description 3
- 229940083181 centrally acting adntiadrenergic agent methyldopa Drugs 0.000 claims description 3
- 229960002896 clonidine Drugs 0.000 claims description 3
- 230000003828 downregulation Effects 0.000 claims description 3
- 235000020650 eye health related herbal supplements Nutrition 0.000 claims description 3
- 206010019233 Headaches Diseases 0.000 claims description 2
- 206010022998 Irritability Diseases 0.000 claims description 2
- 206010027951 Mood swings Diseases 0.000 claims description 2
- 230000002222 downregulating effect Effects 0.000 claims description 2
- 231100000869 headache Toxicity 0.000 claims description 2
- 238000005286 illumination Methods 0.000 claims 2
- 235000020712 soy bean extract Nutrition 0.000 claims 1
- 239000003205 fragrance Substances 0.000 description 14
- 230000035900 sweating Effects 0.000 description 13
- 206010027304 Menopausal symptoms Diseases 0.000 description 12
- 230000009885 systemic effect Effects 0.000 description 12
- 210000003296 saliva Anatomy 0.000 description 11
- 230000007423 decrease Effects 0.000 description 10
- 230000004044 response Effects 0.000 description 9
- 238000011282 treatment Methods 0.000 description 8
- 229940088597 hormone Drugs 0.000 description 6
- 239000005556 hormone Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 241000195940 Bryophyta Species 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229940011871 estrogen Drugs 0.000 description 4
- 239000000262 estrogen Substances 0.000 description 4
- 230000002452 interceptive effect Effects 0.000 description 4
- 235000011929 mousse Nutrition 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000003054 hormonal effect Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000036651 mood Effects 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000906543 Actaea racemosa Species 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 244000062730 Melissa officinalis Species 0.000 description 2
- 235000010654 Melissa officinalis Nutrition 0.000 description 2
- 241000245063 Primula Species 0.000 description 2
- 235000016311 Primula vulgaris Nutrition 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000036626 alertness Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 235000005301 cimicifuga racemosa Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000000865 liniment Substances 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- -1 sticks Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 241000206501 Actaea <angiosperm> Species 0.000 description 1
- 241000269627 Amphiuma means Species 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 206010014759 Endometrial neoplasm Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000238814 Orthoptera Species 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010041347 Somnambulism Diseases 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012495 crackers Nutrition 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000009588 dong quai Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000001632 homeopathic effect Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000002267 hypothalamic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- 229960004296 megestrol acetate Drugs 0.000 description 1
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 238000009527 percussion Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000001369 pituitary-adrenal system Anatomy 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 230000001331 thermoregulatory effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000001521 two-tailed test Methods 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47J—KITCHEN EQUIPMENT; COFFEE MILLS; SPICE MILLS; APPARATUS FOR MAKING BEVERAGES
- A47J19/00—Household machines for straining foodstuffs; Household implements for mashing or straining foodstuffs
- A47J19/06—Juice presses for vegetables
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H7/00—Devices for suction-kneading massage; Devices for massaging the skin by rubbing or brushing not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47J—KITCHEN EQUIPMENT; COFFEE MILLS; SPICE MILLS; APPARATUS FOR MAKING BEVERAGES
- A47J19/00—Household machines for straining foodstuffs; Household implements for mashing or straining foodstuffs
- A47J19/02—Citrus fruit squeezers; Other fruit juice extracting devices
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47J—KITCHEN EQUIPMENT; COFFEE MILLS; SPICE MILLS; APPARATUS FOR MAKING BEVERAGES
- A47J43/00—Implements for preparing or holding food, not provided for in other groups of this subclass
- A47J43/04—Machines for domestic use not covered elsewhere, e.g. for grinding, mixing, stirring, kneading, emulsifying, whipping or beating foodstuffs, e.g. power-driven
- A47J43/07—Parts or details, e.g. mixing tools, whipping tools
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
- A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
- A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
- A61H23/0218—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with alternating magnetic fields producing a translating or oscillating movement
- A61H23/0236—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with alternating magnetic fields producing a translating or oscillating movement using sonic waves, e.g. using loudspeakers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Rehabilitation Therapy (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Food Science & Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/378,384 | 2003-03-03 | ||
| US10/378,384 US20040175438A1 (en) | 2003-03-03 | 2003-03-03 | Methods for alleviating symptoms associated with menopause using sensory regimen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20040078074A true KR20040078074A (ko) | 2004-09-08 |
Family
ID=32824756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020040014394A Ceased KR20040078074A (ko) | 2003-03-03 | 2004-03-03 | 감각요법을 사용하는 폐경기 관련 증상의 완화방법 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20040175438A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1454608A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2004261599A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20040078074A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1539520A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004200845A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0400386A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2459627A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04002059A (cg-RX-API-DMAC7.html) |
| TW (1) | TW200510020A (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2384563A (en) * | 2002-01-29 | 2003-07-30 | Johnson & Johnson Consumer | Method of measuring the stress or relaxation level of a mammal |
| GB0203045D0 (en) * | 2002-02-08 | 2002-03-27 | Johnson & Johnson Consumer | Method of afefecting sleep and sleep-related behaviours |
| WO2007073525A2 (en) * | 2005-11-28 | 2007-06-28 | Yvonne Daily | Hot-flash wipes and clothing |
| JP4802939B2 (ja) * | 2006-08-28 | 2011-10-26 | パナソニック電工株式会社 | 浴室照明装置 |
| US20080057144A1 (en) * | 2006-09-01 | 2008-03-06 | Cathy Beggan | Wake up on time dietary supplement and method of use |
| US20080135437A1 (en) * | 2006-12-11 | 2008-06-12 | Leslie Barnett Taneri | Stress relief sounds in consumer goods |
| GB201111870D0 (en) * | 2011-07-11 | 2011-08-24 | Gandhi Krishna | Method and apparatus for measuring the levels of hormones, neuro transmitters, bio markers or the like |
| EP3102272B1 (en) * | 2014-02-04 | 2019-12-11 | Team Turquoise Ltd. | System for treating a condition of a user |
| CN107920785A (zh) * | 2015-06-05 | 2018-04-17 | 外分泌腺系统公司 | 用于皮质醇测量的汗液感测装置 |
| JP6830206B2 (ja) * | 2016-06-13 | 2021-02-17 | パナソニックＩｐマネジメント株式会社 | 機器制御システム、情報処理装置および機器制御方法 |
| US10850117B2 (en) | 2019-04-16 | 2020-12-01 | Chantal Arnaud | Sonoluminescent Biophysical Oscillation Techniques (SBOT) and method to improve health |
| CN112230575B (zh) * | 2020-09-17 | 2022-04-08 | 惠州拓邦电气技术有限公司 | 低功耗开关检测控制方法、装置及电子设备 |
| CN113663201A (zh) * | 2021-09-13 | 2021-11-19 | 杨璐 | 一种情绪调节室 |
Family Cites Families (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US549771A (en) * | 1895-11-12 | Reamer for use in mining | ||
| IT1019866B (it) * | 1974-08-09 | 1977-11-30 | Biomedix Ag | Apparecchiatura per la determinazio ne della concentrazione di emoglobi na totale ossigenata e risotta car bossiemoglobina del la capacita dell emoglobina per lo ossigeno della saturazione per centuale in ossigeno e in ossido di carbonio nel sangue o in solu zioni di emoglobina |
| EP0053754B1 (de) * | 1980-12-06 | 1986-04-23 | Reichert, Dietrich, Dr. med. | Mittel zur Bekämpfung des Schnarchens und Verfahren zu dessen Anwendung |
| US4375421A (en) * | 1981-10-19 | 1983-03-01 | Lever Brothers Company | Viscous compositions containing amido betaines and salts |
| LU84752A1 (fr) * | 1983-04-15 | 1984-11-28 | Oreal | Composition lavante et moussante a base d'agents tensio-actifs et de polymeres anioniques |
| LU84753A1 (fr) * | 1983-04-15 | 1984-11-28 | Oreal | Composition lavante et moussante a base d'agents tensio-actifs non ioniques et de polymeres anioniques |
| US4671959A (en) * | 1984-11-14 | 1987-06-09 | Yale University | Method of causing the reduction of physiological and/or subjective reactivity to stress in humans being subjected to stress conditions |
| JPS61267526A (ja) * | 1984-11-14 | 1986-11-27 | インタ−ナシヨナル フレイバ−ス アンド フレグランシス インコ−ポレイテツド | 人間のストレスに対する生理的及び、又は主観的反応性を減少させる医薬 |
| EP0269107A3 (en) * | 1986-11-28 | 1989-10-11 | Kao Corporation | Composition for hair treatment agent |
| US4877322A (en) * | 1987-04-30 | 1989-10-31 | Eyedentify, Inc. | Method and apparatus for measuring blood oxygen levels in selected areas of the eye fundus |
| FR2632519B1 (fr) * | 1988-06-14 | 1992-02-21 | Oreal | Composition parfumante, a phase aqueuse continue, ayant une forte concentration en parfum |
| US5564417A (en) * | 1991-01-24 | 1996-10-15 | Non-Invasive Technology, Inc. | Pathlength corrected oximeter and the like |
| US5711899A (en) * | 1988-12-23 | 1998-01-27 | Henkel Kommanditgesellschaft Auf Aktien | Free flowing pearlescent concentrate |
| DE3930725A1 (de) * | 1989-09-14 | 1991-03-21 | Benckiser Gmbh Joh A | Extra-milde duschgel- und haarshampoo-formulierung mit niedriger tensidkonzentration |
| US5063062A (en) * | 1989-09-27 | 1991-11-05 | D. Greenspan | Cleaning compositions with orange oil |
| AU630561B2 (en) * | 1990-06-12 | 1992-10-29 | Cathy Palou | A therapeutic preparation containing myrrh for treating skin disorders |
| US5614553A (en) * | 1990-07-06 | 1997-03-25 | Albion Laboratories, Inc. | Composition and method for alleviating stress in warm-blooded animals |
| US5304112A (en) * | 1991-10-16 | 1994-04-19 | Theresia A. Mrklas | Stress reduction system and method |
| US5318503A (en) * | 1991-12-27 | 1994-06-07 | Lord Robert F | Method and apparatus for auditory and olfactory relaxation |
| US5275761A (en) * | 1992-04-15 | 1994-01-04 | Helene Curtis, Inc. | Conditioning shampoo composition and method of preparing and using the same |
| US5403263A (en) * | 1992-05-21 | 1995-04-04 | P.I.P. Surgical Audiotape Series, Inc. | Method of reducing the recovery time and stress associated with surgery |
| US5284603A (en) * | 1992-06-03 | 1994-02-08 | Colgate Palmolive Co. | Gelled detergent composition having improved skin sensitivity |
| US5403587A (en) * | 1993-04-22 | 1995-04-04 | Eastman Kodak Company | Disinfectant and sanitizing compositions based on essential oils |
| US5578312A (en) * | 1993-05-05 | 1996-11-26 | Parrinello; Vincene M. | Skin care system and method for improving moisture retention in skin |
| GB9321479D0 (en) * | 1993-10-18 | 1993-12-08 | Scotia Holdings Plc | Stabilisation of polyunsaturates |
| US5597406A (en) * | 1993-11-02 | 1997-01-28 | Henkel Corporation | Method of thickening aqueous formulations |
| US5501813A (en) * | 1993-11-02 | 1996-03-26 | Henkel Corporation | Thickener for aqueous compositions |
| US5466446A (en) * | 1994-02-16 | 1995-11-14 | Stiefel Laboratories, Inc. | Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof |
| DE4416566A1 (de) * | 1994-05-11 | 1995-11-16 | Huels Chemische Werke Ag | Wäßrige viskoelastische Tensidlösungen zur Haar- und Hautreinigung |
| JPH10501275A (ja) * | 1994-05-31 | 1998-02-03 | ザ、プロクター、エンド、ギャンブル、カンパニー | クリーニング組成物 |
| US5540853A (en) * | 1994-10-20 | 1996-07-30 | The Procter & Gamble Company | Personal treatment compositions and/or cosmetic compositions containing enduring perfume |
| US5849310A (en) * | 1994-10-20 | 1998-12-15 | The Procter & Gamble Company | Personal treatment compositions and/or cosmetic compositions containing enduring perfume |
| US5716919A (en) * | 1995-05-09 | 1998-02-10 | The Andrew Jergens Company | Mild cleansing formulation with a hydroxy-containing compound, a nonionic surfactant and an anionic surfactant |
| US5607980A (en) * | 1995-07-24 | 1997-03-04 | The Procter & Gamble Company | Topical compositions having improved skin feel |
| US5771261A (en) * | 1995-09-13 | 1998-06-23 | Anbar; Michael | Telethermometric psychological evaluation by monitoring of changes in skin perfusion induced by the autonomic nervous system |
| US5855884A (en) * | 1995-11-27 | 1999-01-05 | Kos Pharmaceuticals, Inc. | Treatment of stress-induced migraine headache with a corticotropin releasing hormone blocker |
| US5904916A (en) * | 1996-03-05 | 1999-05-18 | Hirsch; Alan R. | Use of odorants to alter learning capacity |
| US5792739A (en) * | 1996-04-24 | 1998-08-11 | Lever Brothers Company, Division Of Conopco, Inc. | Liquid compositions comprising hydrophobically modified polyalkylene glycols as mildness actives |
| US5789953A (en) * | 1996-05-29 | 1998-08-04 | Integrated Device Technology, Inc. | Clock signal generator providing non-integer frequency multiplication |
| US5804538A (en) * | 1996-06-20 | 1998-09-08 | The Procter & Gamble Company | Perfume delivery systems in liquid personal cleansing compositions |
| US5753637A (en) * | 1996-10-09 | 1998-05-19 | Ideal Ideas, Inc. | Method of treating acne conditions |
| US5922331A (en) * | 1997-03-26 | 1999-07-13 | Chanel, Inc. | Skin cream composition |
| US5958462A (en) * | 1997-05-23 | 1999-09-28 | Mclean; Linsey | Therapeutic bath salts and method of use |
| US5916576A (en) * | 1997-05-30 | 1999-06-29 | Amway Corporation | Method of scavenging free radicals using orange extract |
| CN1278819A (zh) * | 1997-09-02 | 2001-01-03 | 杜邦药品公司 | 作为促肾上腺皮质素释放激素拮抗剂、可用于治疗cns障碍和紧张相关性疾病的杂环基取代的环稠合吡啶和嘧啶 |
| US5980925A (en) * | 1997-12-30 | 1999-11-09 | Ethicon, Inc. | High glycerin containing anti-microbial cleansers |
| JP2000053532A (ja) * | 1998-08-04 | 2000-02-22 | Shiseido Co Ltd | 美容法 |
| ES2258479T3 (es) * | 1999-10-01 | 2006-09-01 | JOHNSON & JOHNSON CONSUMER COMPANIES, INC. | Tecnica que permite calmar a las personas con la ayuda de composiciones de tratamientos personales. |
| US20020151527A1 (en) * | 2000-12-20 | 2002-10-17 | Benjamin Wiegand | Method for reducing acne or improving skin tone |
| US6428466B1 (en) * | 2001-02-14 | 2002-08-06 | Simulated Environment Concepts, Inc. | Spa capsule |
-
2003
- 2003-03-03 US US10/378,384 patent/US20040175438A1/en not_active Abandoned
-
2004
- 2004-03-02 JP JP2004057807A patent/JP2004261599A/ja active Pending
- 2004-03-02 CA CA002459627A patent/CA2459627A1/en not_active Abandoned
- 2004-03-02 AU AU2004200845A patent/AU2004200845A1/en not_active Abandoned
- 2004-03-02 EP EP04251206A patent/EP1454608A1/en not_active Ceased
- 2004-03-02 TW TW093105444A patent/TW200510020A/zh unknown
- 2004-03-03 CN CNA2004100330262A patent/CN1539520A/zh active Pending
- 2004-03-03 MX MXPA04002059A patent/MXPA04002059A/es unknown
- 2004-03-03 KR KR1020040014394A patent/KR20040078074A/ko not_active Ceased
- 2004-03-03 BR BR0400386-1A patent/BRPI0400386A/pt not_active IP Right Cessation
-
2007
- 2007-01-15 US US11/623,173 patent/US20070141179A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004200845A1 (en) | 2004-09-23 |
| JP2004261599A (ja) | 2004-09-24 |
| EP1454608A1 (en) | 2004-09-08 |
| MXPA04002059A (es) | 2005-02-17 |
| US20040175438A1 (en) | 2004-09-09 |
| US20070141179A1 (en) | 2007-06-21 |
| TW200510020A (en) | 2005-03-16 |
| CN1539520A (zh) | 2004-10-27 |
| CA2459627A1 (en) | 2004-09-03 |
| BRPI0400386A (pt) | 2005-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070141179A1 (en) | Methods for alleviating symptoms associated with menopause using sensory regimen | |
| US20070275102A9 (en) | Method of affecting sleep and sleep-related behaviors | |
| Soni et al. | Evaluation of the efficacy of aromatherapy on anxiety level among pediatric patients in a dental setting: a randomized control trial | |
| US20020146469A1 (en) | Methods for reducing chronic stress in mammals | |
| AU2008203320A1 (en) | Method for reducing acne or improving skin tone | |
| KR101074955B1 (ko) | 생리/심리적 치료 효과를 갖는 향료 조성물 | |
| Surridge-David et al. | Mood change following an acute delay of sleep | |
| US20050065100A1 (en) | Method for reducing acne or improving skin tone | |
| Mendelson | Efficacy of melatonin as a hypnotic agent | |
| JP2004261599A5 (cg-RX-API-DMAC7.html) | ||
| MXPA03005747A (es) | Metodos para medir la tension nerviosa en mamiferos. | |
| Permatha | The Effect of Lavender Inhalation Aromatherapy on Sleep Quality of the Elderly at Tresna Werdha Social Institution Jambi City | |
| Kirk-Smith | The psychological effects of lavender II: scientific and clinical evidence | |
| AU2007207879A1 (en) | Methods for reducing chronic stress in mammals | |
| Abbasi et al. | Effects of Binaural Beat and Lavender Scent Inhalation on mood and Sleep Quality of Female Student-Athletes with Sleep Disorders | |
| AU2003200289A1 (en) | Method of affecting sleep and sleep-related behaviours | |
| Saletu | Therapy for sleep disorders in depressives | |
| Sidik et al. | Music Therapy in Medicine | |
| RU2219966C1 (ru) | Способ замедления образования возрастных косметических дефектов | |
| RU2219967C1 (ru) | Способ замедления образования возрастных косметических дефектов | |
| Levin | “MUSIC OF THE BRAIN” IN TREATMENT OF INSOMNIA PATIENTS (DOUBLE BLIND RESEARCH). | |
| Leske | The Effect of Individualised Homeopathic Treatment on Insomnia Disorder in Females | |
| Tanigawa | 3 PLOS| os |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20040303 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20090303 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20040303 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20110331 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20110616 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20110331 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |